“Comparative Efficacy of Tirzepatide, Teneligliptin, and Empagliflozin in HbA1c Reduction in Patients With Type 2 Diabetes: A Systematic Review and Meta-Analysis”. 2023. International Journal of Medical and Surgical Sciences 10 (3): 1-18. https://doi.org/10.32457/ijmss.v10i3.2263.